Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes: A Target Trial Emulation

NCT07708610 is registered in ClinicalTrials.gov with Chung Shan Medical University as lead sponsor.

NCT NCT07708610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07708610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes: A Target Trial Emulation
Lead sponsor
Chung Shan Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
August 31, 2026
Enrollment
71,775 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia, type 2 diabetes mellitus (t2dm)